Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › pioglitazone

pioglitazone

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of pioglitazone

100 trials tracked of pioglitazone: 50 in phase 3 or 4 and 10 with published results. The most-cited published study has 310 citations.

100Trials tracked
50Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 21 Phase 3 29 Phase 2 29 Phase 1 1 Other / NA 20
  1. Phase 4 Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment Completed · 310 cited
  2. Phase 3 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone Completed · 137 cited
  3. Phase 4 Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes Completed · 108 cited
  4. Phase 3 Insulin Resistance Intervention After Stroke Trial Completed · 108 cited
  5. Phase 3 Actos Now for Prevention of Diabetes (ACT NOW) Completed · 102 cited
  6. Phase 3 PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease Completed · 71 cited
Show 44 more trials
  1. Phase 4 Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) Completed · 63 cited
  2. Phase 4 Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Completed · 53 cited
  3. Phase 4 Pioglitazone in Patients With Mood Disorders Completed · 35 cited
  4. Phase 3 Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus Completed · 9 cited
  5. Phase 4 Metabolic Abnormalities in HIV-infected Persons Completed
  6. Phase 4 Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4? Completed
  7. Phase 4 Response To Oral Agents in Diabetes (ROAD)- Pilot Study Completed
  8. Phase 4 Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy Completed
  9. Phase 4 The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans Completed
  10. Phase 4 Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose. Completed
  11. Phase 4 Renal and Hormonal Effects of Pioglitazone Completed
  12. Phase 4 Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes Completed
  13. Phase 4 Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects Completed
  14. Phase 4 Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance Completed
  15. Phase 4 Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea Completed
  16. Phase 4 Optimizing Body Composition for Function in Older Adults Completed
  17. Phase 4 Mechanisms Underlying Metabolic Syndrome in Obesity Completed
  18. Phase 4 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance. Completed
  19. Phase 4 Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes Completed
  20. Phase 4 Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function Completed
  21. Phase 3 A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed
  22. Phase 3 Study of Rivoglitazone in Type 2 Diabetes Mellitus Completed
  23. Phase 3 Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone Completed
  24. Phase 3 The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) Completed
  25. Phase 3 Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes Completed
  26. Phase 3 A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Completed
  27. Phase 3 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Completed
  28. Phase 3 Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) Completed
  29. Phase 3 Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes Completed
  30. Phase 3 A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone Completed
  31. Phase 3 Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus Completed
  32. Phase 3 Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan Completed
  33. Phase 3 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Completed
  34. Phase 3 Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Completed
  35. Phase 3 Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus Completed
  36. Phase 3 A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes Completed
  37. Phase 3 Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus Completed
  38. Phase 3 A Study in Participants With Type 2 Diabetes Mellitus Completed
  39. Phase 3 Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) Completed
  40. Phase 3 A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) Completed
  41. Phase 3 Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. Completed
  42. Phase 3 Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. Completed
  43. Phase 3 Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) Completed
  44. Phase 3 MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) Completed

Showing the 50 most-cited and recently-updated of 100 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cochrane review finds uncertain benefits of drugs for Friedreich ataxia with low-certainty evidence
Cardiology Sys. Review
Cochrane review finds uncertain benefits of drugs for Friedreich ataxia with low-certainty evidence Cochrane review finds little benefit for drugs treating Friedreich ataxia
This Cochrane systematic review evaluated pharmacological treatments for people with genetically-confirmed Friedreich ataxia. The analysis i…
A major review of eight studies found that most drugs for Friedreich ataxia likely make little difference to key symptoms compared to placeb…
Cochrane May 16, 2026
Bayesian network meta-analysis evaluates antidiabetic medications and dementia risk in 4,382,897 patients
Diabetes & Endocrinology Meta-analysis
Bayesian network meta-analysis evaluates antidiabetic medications and dementia risk in 4,382,897 patients Could diabetes drugs lower dementia risk, or raise it for some patients?
This Bayesian network meta-analysis synthesized data from 28 articles involving 4,382,897 patients to assess antidiabetic drugs and dementia…
Insulin and metformin cut dementia risk, but DPP4 inhibitors may double Alzheimer's risk compared to SGLT2 drugs in diabetes patients.
Frontiers Apr 16, 2026
Mini-review links insulin to worse COVID-19 outcomes in type 2 diabetes patients
Nephrology RCT
Mini-review links insulin to worse COVID-19 outcomes in type 2 diabetes patients Diabetes Meds Do Not Stop COVID-19
A mini-review of observational studies in patients with type 2 diabetes mellitus found that insulin was linked to worse COVID-19 outcomes, w…
Recent research proves that common diabetes pills do not protect you from getting sick or dying from a virus infection.
Frontiers Apr 15, 2026
Phase 4 trial compares pioglitazone versus dapagliflozin add-on in type 2 diabetes
Diabetes & Endocrinology Phase IV
Phase 4 trial compares pioglitazone versus dapagliflozin add-on in type 2 diabetes Trial compares two diabetes drug combinations but results are not yet available
A phase 4 randomized controlled trial in South Korea enrolled 133 participants with type 2 diabetes inadequately controlled by DPP-4 inhibit…
A completed trial in South Korea compared two three-drug combinations for type 2 diabetes, but results on blood sugar control are not yet av…
CT.gov Apr 3, 2026